• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妇科肿瘤学中的盆腔脏器清除术:西奈山中心的经验,1975 - 1992年

Pelvic exenteration in gynecologic oncology: Experience at the Mount Sinai Center, 1975-1992.

作者信息

Dottino P R, Segna R A, Jennings T S, Mandeli J P, Konsker K, Cohen C J

机构信息

Department of Obstetrics, Gynecology and Reproductive Sciences, Mount Sinai Medical Center, New York, NY 10029, USA.

出版信息

Mt Sinai J Med. 1995 Nov;62(6):431-5.

PMID:8692157
Abstract

Thirty-nine patients underwent pelvic exenteration for gynecologic malignancies at The Mount Sinai Medical Center between 1975 and 1992. Surgical techniques, morbidity, survival, and other variables for patients so treated in two periods, 1975-1984 and 1985-1992, were compared. The primary cancer included squamous cell carcinoma of the cervix, 27; adenocarcinoma of the cervix, 1; squamous cell carcinoma of the vagina, 4; adenocarcinoma of the endometrium, 4; squamous cell carcinoma of the vulva, 2; and adenocarcinoma of the rectum, 1. Median survival was 23.1 months, with a median follow-up of 18 months. Survival was significantly related to status of the lymph nodes (p 0.0004) and surgical margins (p 0.0038). There were two postoperative mortalities, one due to pulmonary embolus and another to myocardial infarction. The ability in the second period analyzed, 1985-1992, to integrate a continent urinary reservoir and supralevator exenteration without colostomy yet not induce increased morbidity or decreased survival, has not been previously reported.

摘要

1975年至1992年间,39例患者在西奈山医学中心因妇科恶性肿瘤接受了盆腔脏器清除术。对1975 - 1984年和1985 - 1992年这两个时期接受该治疗的患者的手术技术、发病率、生存率及其他变量进行了比较。原发性癌症包括子宫颈鳞状细胞癌27例;子宫颈腺癌1例;阴道鳞状细胞癌4例;子宫内膜腺癌4例;外阴鳞状细胞癌2例;直肠腺癌1例。中位生存期为23.1个月,中位随访时间为18个月。生存率与淋巴结状态(p = 0.0004)和手术切缘(p = 0.0038)显著相关。术后有2例死亡,1例死于肺栓塞,另1例死于心肌梗死。在1985 - 1992年分析的第二个时期,能够整合可控性尿流改道术和经肛提肌外盆腔脏器清除术而无需结肠造口,且不增加发病率或降低生存率,此前尚未见报道。

相似文献

1
Pelvic exenteration in gynecologic oncology: Experience at the Mount Sinai Center, 1975-1992.妇科肿瘤学中的盆腔脏器清除术:西奈山中心的经验,1975 - 1992年
Mt Sinai J Med. 1995 Nov;62(6):431-5.
2
Pelvic exenteration, University of Michigan: 100 patients at 5 years.密歇根大学盆腔脏器清除术:100例患者的5年随访情况
Obstet Gynecol. 1989 Dec;74(6):934-43.
3
Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.晚期妇科恶性肿瘤患者盆腔廓清术的长期临床结局。
J Surg Oncol. 2010 May 1;101(6):507-12. doi: 10.1002/jso.21518.
4
Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies.妇科恶性肿瘤全盆腔脏器清除术中直肠系膜淋巴结受累情况及其预后意义
Gynecol Oncol. 2006 Mar;100(3):533-6. doi: 10.1016/j.ygyno.2005.08.039. Epub 2005 Oct 14.
5
[Laparoscopy-assisted vaginal pelvic exenteration].腹腔镜辅助经阴道盆腔脏器清扫术
Gynecol Obstet Fertil. 2006 Dec;34(12):1131-6. doi: 10.1016/j.gyobfe.2006.09.025. Epub 2006 Nov 28.
6
Pelvic exenteration for primary and recurrent gynaecological malignancies.原发性和复发性妇科恶性肿瘤的盆腔脏器切除术
Eur J Obstet Gynecol Reprod Biol. 2007 Oct;134(2):243-8. doi: 10.1016/j.ejogrb.2006.07.025. Epub 2006 Sep 6.
7
Pelvic exenteration. Has it a role in 1987? A six year experience.盆腔脏器清除术。它在1987年是否有作用?六年的经验。
Verh K Acad Geneeskd Belg. 1989;51(1):31-44; discussion 44-6.
8
Total pelvic exenteration as a therapeutic option in advanced malignant disease of the pelvis.全盆腔脏器切除术作为盆腔晚期恶性疾病的一种治疗选择。
Surg Gynecol Obstet. 1988 Mar;166(3):259-63.
9
[Preliminary experience with the Miami type ileocolonic urinary reservoir in the practice of oncologic gynecology].[迈阿密型回结肠泌尿储袋在肿瘤妇科实践中的初步经验]
Arch Esp Urol. 2001 May;54(4):327-33.
10
Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies.复发性妇科恶性肿瘤行盆腔脏器清除术患者的可控性尿流改道术及低位直肠吻合术。
Gynecol Oncol. 2000 Aug;78(2):208-11. doi: 10.1006/gyno.2000.5864.